Bipolar disorder: New perspectives in health care and prevention

Journal of Clinical Psychiatry

Volumn 71, Issue 12, 2010, Pages 1689-1695

  Leboyer, Marion ^a,b,c,d,e   Kupfer, David J ^e  

^a Hopital Albert Chenevier   (France)

^b INSERM   (France)

^c FondaMental Fondation de Recherche et de Soins en Santé Mentale   (France)

^d European Network of Bipolar Research Expert Centres (ENBREC)   (France)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIPOLAR DISORDER; CIRCADIAN RHYTHM SLEEP DISORDER; COGNITIVE DEFECT; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERROR; DISEASE COURSE; HEALTH CARE; HUMAN; HYPERSOMNIA; INSOMNIA; LONG TERM CARE; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

AGE OF ONSET; BIPOLAR DISORDER; CHRONIC DISEASE; COGNITION; COMORBIDITY; DELIVERY OF HEALTH CARE; DISEASE PROGRESSION; HUMANS; INDIVIDUALIZED MEDICINE; RISK FACTORS; SLEEP; TREATMENT OUTCOME;

EID: 78650472671     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06347yel     Document Type: Article

References (55)

1. Murray C, Lopez A. The Global Burden of Disease. A Comprehensive Assessment of Morbidity and Disability From Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, Massachusetts: Harvard University Press; 1996.
2. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543-552.
3. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64(1):53-59.
4. Baca-Garcia E, Perez-Rodriguez MM, Basurte-Villamor I, et al. Diagnostic stability and evolution of bipolar disorder in clinical practice: a prospective cohort study. Acta Psychiatr Scand. 2007;115(6):473-480.
5. Bryant-Comstock L, Stender M, Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord. 2002;4(6):398-405.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
7. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59(6):530-537.
8. Fagiolini A, Kupfer DJ, Masalehdan A, et al. Functional impairment in the remission phase of bipolar disorder. Bipolar Disord. 2005;7(3): 281-285.
9. Altshuler LL, Post RM, Black DO, et al. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. J Clin Psychiatry. 2006;67(10): 1551-1560.
10. Regier DA, Narrow WE, Kuhl EA, et al. The conceptual development of DSM-V. Am J Psychiatry. 2009;166(6):645-650.
11. Henry C, Van den Bulke D, Bellivier F, et al. Affective lability and affect intensity as core dimensions of bipolar disorders during euthymic period. Psychiatry Res. 2008;159(1-2):1-6.
12. Phillips ML, Ladouceur CD, Drevets WC. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry. 2008;13(9):829, 833-857.
13. Houenou J, Wessa M, Douaud G, et al. Increased white matter connectivity in euthymic bipolar patients: diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex. Mol Psychiatry. 2007;12(11):1001-1010.
14. Zahn TP, Nurnberger JI Jr, Berrettini WH. Electrodermal activity in young adults at genetic risk for affective disorder. Arch Gen Psychiatry. 1989;46(12):1120-1124.
15. Krüger S, Alda M, Young LT, et al. Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry. 2006;163(2):257-264.
16. Malkoff-Schwartz S, Frank E, Anderson B, et al. Stressful life events and social rhythm disruption in the onset of bipolar and unipolar episodes. Arch Gen Psychiatry. 1998;55:702-707.
17. Etain B, Henry C, Bellivier F, et al. Beyond genetics: childhood affective trauma in bipolar disorder. Bipolar Disord. 2008;10(8):867-876.
18. McClure-Tone E. Socioemotional functioning in bipolar disorder versus typical development: behavioral and neural differences. Clin Psychol Sci Pract. 2009;16(2):98-113.
19. Surguladze SA, Marshall N, Schulze K, et al. Exaggerated neural response to emotional faces in patients with bipolar disorder and their first-degree relatives. Neuroimage. 2010;53(1):58-64.
20. Almeida JR, Versace A, Hassel S, et al. Elevated amygdala activity to sad facial expressions: a state marker of bipolar but not unipolar depression. Biol Psychiatry. 2010;67(5):414-421.
21. Rosa AR, Reinares M, Franco C, et al. Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord. 2009;11(4): 401-409.
22. Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry. 2008;165(7): 820-829.
23. Millar A, Espie CA, Scott J. The sleep of remitted bipolar outpatients: a controlled naturalistic study using actigraphy. J Affect Disord. 2004; 80(2-3):145-153.
24. Harvey AG, Schmidt DA, Scarnà A, et al. Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems. Am J Psychiatry. 2005;162(1):50-57.
25. Nurnberger JI Jr, Adkins S, Lahiri DK, et al. Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry. 2000;57(6):572-579.
26. Mansour HA, Monk TH, Nimgaonkar VL. Circadian genes and bipolar disorder. Ann Med. 2005;37(3):196-205.
27. Roybal K, Theobold D, Graham A, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A. 2007;104(15): 6406-6411.
28. Yoo S-S, Gujar N, Hu P, et al. The human emotional brain without sleep - a prefrontal amygdala disconnect. Curr Biol. 2007;17(20): R877-R878.
29. Frank E, Kupfer DJ, Thase ME, et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry. 2005;62(9):996-1004.
30. Goodwin GM, Martinez-Aran A, Glahn DC, et al. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? an ECNP expert meeting report. Eur Neuropsychopharmacol. 2008;18(11):787-793.
31. Arts B, Jabben N, Krabbendam L, et al. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med. 2008;38(6):771-785.
32. Martinez-Aran A, Vieta E, Torrent C, et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007;9(1-2):103-113.
33. Colom F, Vieta E, Martínez-Arán A, et al. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry. 2000;61(8):549-555.
34. Martinez-Aran A, Scott J, Colom F, et al. Treatment nonadherence and neurocognitive impairment in bipolar disorder. J Clin Psychiatry. 2009; 70(7):1017-1023.
35. Henry C, M'bailara K, Lépine JP, et al. Defining bipolar mood states with quantitative measurement of inhibition/activation and emotional reactivity. (published online ahead of print June 7, 2010) J Affect Disord. 2010.
36. Grunze H, Vieta E, Goodwin GM, et al; WFSBP Task Force On Treatment Guidelines For Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010;11(2):81-109.
37. Vieta E, Pacchiarotti I, Valentí M, et al. A critical update on psychological interventions for bipolar disorders. Curr Psychiatry Rep. 2009;11(6): 494-502.
38. Perlick DA, Rosenheck RA, Miklowitz DJ, et al; STEP-BD Family Experience Collaborative Study Group. Prevalence and correlates of burden among caregivers of patients with bipolar disorder enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder. Bipolar Disord. 2007;9(3):262-273.
39. Schürhoff F, Bellivier F, Jouvent R, et al. Early and late onset bipolar disorders: two different forms of manic-depressive illness? J Affect Disord. 2000;58(3):215-221.
40. Perlis RH, Dennehy EB, Miklowitz DJ, et al. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord. 2009;11(4):391-400.
41. Miklowitz DJ, Scott J. Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions. Bipolar Disord. 2009;11(suppl 2):110-122.
42. Fajutrao L, Locklear J, Priaulx J, et al. A systematic review of the evidence of the burden of bipolar disorder in Europe. Clin Pract Epidemol Ment Health. 2009;5(1):3.
43. Parikh SV, LeBlanc SR, Ovanessian MM. Advancing bipolar disorder: key lessons from the systematic treatment enhancement program for bipolar disorder (STEP-BD). Can J Psychiatry. 2010;55(3):136-143.
44. Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatr Serv. 2009;60(2):147-156.
45. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA. 2005;293(20):2528-2530.
46. Fagiolini A, Kupfer DJ, Houck PR, et al. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry. 2003;160(1):112-117.
47. Jerrell J, McIntyre R, Tripathi A. A cohort study of the prevalence of comorbid medical conditions in pediatric bipolar disorder. (published online ahead of print June 15, 2010) J Clin Psychiatry. 2010.
48. Taylor V, MacQueen G. Associations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry. 2006;67(7):1034-1041.
49. Alsuwaidan MT, Kucyi A, Law CW, et al. Exercise and bipolar disorder: a review of neurobiological mediators. Neuromolecular Med. 2009;11(4): 328-336.
50. McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci. 2004;1032(1):1-7.
51. Goldstein BI, Kemp DE, Soczynska JK, et al. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry. 2009; 70(8):1078-1090.
52. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000;157(5):683-694.
53. Scott J, Paykel E, Morriss R, et al. A randomized controlled trial of CBT versus usual treatment in severe and recurrent bipolar disorders. Br J Psychiatry. 2006;188:313-320.
54. Vieta E. The European network for bipolar disorder. ECNP Matters. 2008;14(6):4. http://matters.ecnp.nl/number14/network.shtml. Accessed September 24, 2010.
55. Insel TR. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch Gen Psychiatry. 2009; 66(2):128-133.